bioRxivCancer BiologyPreprint
Tumour suppressors LKB1 and SMARCA4 functionally interact to regulate gene expression of diverse biological processes in lung cancer
Abstract
The tumour suppressor kinase LKB1 is known to regulate the activity of the metabolic sensor AMPK, that when under energy stress shifts metabolism from anabolism to catabolism, thus linking LKB1 to AMPK-mediated gene expression. Coupled with its role as a tumour suppressor kinase, LKB1 is an important metabolic regulator implicated in multiple malignancies and is frequently mutated in lung cancer. Previously, we discovered that LKB1 binds to the SWI/SNF chromatin remodelling ATP-dependent helicase subunit SMARCA4, directly linking LKB1 to gene expression. How LKB1 and SMARCA4 collaborate to regulate gene expression in lung cancer has not been well characterized. We used an in-silico approach to explore how LKB1 and SMARCA4 may cooperate to regulate gene expression. We mined our previous scRNA-seq dataset from 4 lung cancer cell lines with differential LKB1 and SMARCA4 expression status to identify genes regulated by both LKB1 and SMARCA4. We correlated our results using bulk RNA-seq results from human lung tumours. We show that LKB1 and SMARCA4 likely function together to regulate gene expression in multiple biological processes in lung cancer cell lines. Gene expression profiles from LKB1 and SMARCA4 mutant cells are similar, suggesting LKB1 and SMARCA4 function in a linear pathway to regulate gene expression. Furthermore, we observed similar results in human lung tumours, particularly in late-stage disease. We propose a model where LKB1 acts as a nexus between metabolism and gene expression, acting via the SMARCA4-SWI/SNF complex to regulate gene expression in lung cancer.
- organism: human
- assay: scRNA-seq
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SMARCA4 supports the oncogenic landscape of KRAS-driven lung tumors
E. Collisson·bioRxiv·Apr 18, 2020
- Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression ofPAK3 via miRNA regulation
- SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma
Emily A. Costa, Barbara Vaz de Mello, … Charles M. Rudin·Translational OncologyPeer-reviewed·Jul 20, 2026
- Dependency of LKB1-inactivated lung cancer on aberrant CRTC-CREB activation
- SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer
Nicole A. Kirk, Jin Ng, … Kwon-Sik Park·bioRxiv·May 21, 2025
- In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1-mutant lung cancer
J. Deng, D. H. Peng, … K.-K. Wong·bioRxiv·Apr 18, 2023